These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 27271348)

  • 1. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
    Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
    Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes.
    Luopajärvi K; Skarsvik S; Ilonen J; Akerblom HK; Vaarala O
    Immunology; 2007 Jun; 121(2):189-96. PubMed ID: 17244154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
    Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
    Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
    Abraham RS; Kudva YC; Wilson SB; Strominger JL; David CS
    Diabetes; 2000 Apr; 49(4):548-54. PubMed ID: 10871191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
    Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
    Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No extreme genetic risk for type 1 diabetes among DR3/4-DQ8 siblings sharing both extended HLA haplotypes with their diabetic proband.
    Eerligh P; Koeleman BP; Lie BA; Roep BO; Thorsby E
    Tissue Antigens; 2011 Apr; 77(4):338-40. PubMed ID: 21388358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
    Wen L; Chen NY; Tang J; Sherwin R; Wong FS
    J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.
    Rajagopalan G; Kudva YC; Chen L; Wen L; David CS
    Int Immunol; 2003 Sep; 15(9):1035-44. PubMed ID: 12917255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.
    Ellis RJ; Varela-Calvino R; Tree TI; Peakman M
    Immunology; 2005 Nov; 116(3):337-46. PubMed ID: 16236123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes.
    Hannelius U; Beam CA; Ludvigsson J
    Diabetologia; 2020 Oct; 63(10):2177-2181. PubMed ID: 32754804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
    Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
    J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human islets and dendritic cells generate post-translationally modified islet autoantigens.
    McLaughlin RJ; de Haan A; Zaldumbide A; de Koning EJ; de Ru AH; van Veelen PA; van Lummel M; Roep BO
    Clin Exp Immunol; 2016 Aug; 185(2):133-40. PubMed ID: 26861694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.